{"organizations": [], "uuid": "178897847f3e2c99afe075c18df0d84970cefdcc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "https://fm.cnbc.com/applications/cnbc.com/resources/img/editorial/2018/05/18/105218225-724238185.600x400.jpg", "site_section": "http://www.cnbc.com/id/100004038/device/rss/rss.html", "section_title": "Latest Video", "url": "https://www.cnbc.com/video/2018/05/18/amgens-migraine-treatment-focuses-on-huge-un-met-need-says-analyst.html", "country": "US", "domain_rank": 767, "title": "Amgen's migraine treatment focuses on huge un-met need, says analyst", "performance_score": 0, "site": "cnbc.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-18T21:03:00.000+03:00", "replies_count": 0, "uuid": "178897847f3e2c99afe075c18df0d84970cefdcc"}, "author": "", "url": "https://www.cnbc.com/video/2018/05/18/amgens-migraine-treatment-focuses-on-huge-un-met-need-says-analyst.html", "ord_in_thread": 0, "title": "Amgen's migraine treatment focuses on huge un-met need, says analyst", "locations": [], "entities": {"persons": [{"name": "michael yee", "sentiment": "negative"}, {"name": "jeffer", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "amgen", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Amgen's migraine treatment focuses on huge un-met need, says analyst 3 Hours Ago Michael Yee, Jefferies, discusses what Amgenâ€™s new migraine treatment means for the company and the pharma space.", "external_links": [], "published": "2018-05-18T21:03:00.000+03:00", "crawled": "2018-05-19T00:09:33.011+03:00", "highlightTitle": ""}